MedTrace Logo

Clinical Performance of a Chlorhexidine Antimicrobial Dressing

NCT00516906 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-10-24

Study results available
· View outcomes & findings →

Summary

Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing

Conditions

  • Catheterization

Interventions

DRUG

Chlorhexidine gluconate

2% Chlorhexidine Transparent Dressing applied as needed up to 7 days of wear

DRUG

Transparent Adhesive Dressing

Standard of Care Non-antimicrobial Transparent Adhesive Dressing applied as needed for up to 7 days of wear

Sponsors & Collaborators

  • University of Nebraska

    collaborator OTHER

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Mark E Rupp, M.D. · Nebraska Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-12-31
Completion
2008-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00516906 on ClinicalTrials.gov